Combination GnRH antagonists for endometriosis: Balancing efficacy with side effects.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 36130483.
- Also identified by DOI 10.1016/j.xcrm.2022.100748 and PMC identifier 9512692.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Endometriosis is a chronic pain condition affecting 1 in 10 women. There is an unmet need for better medical treatments for endometriosis. We spotlight trials of a single preparation combined HRT-GnRH antagonist (Relugolix) by Giudice et al.,<sup>1</sup> for endometriosis-associated pain.
Medical subject headings
- Drug-Related Side Effects and Adverse Reactions
- Endometriosis